Soluble IL-2R: A potential therapeutic target for mitochondrial dysfunction in post-COVID fatigue syndrome
1. Department of Physiology, University of Kentucky, Lexington, Kentucky, USA
2. Center for Muscle Biology, University of Kentucky, Lexington, Kentucky, USA
3. Department of Physical Therapy, Augusta University, Augusta, Georgia, USA
4. Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of Kentucky, Lexington, Kentucky, USA
5. Department of Microbiology, Immunology, and Molecular Genetics, University of Kentucky, Lexington, Kentucky, USA
6. Spinal Cord and Brain Injury Research Center, University of Kentucky, Lexington, Kentucky, USA
7. Department of Neurosurgery, Medical University of South Carolina, Charleston, South Carolina, USA
8. Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
9. Department of Biology, Baylor University, Waco, Texas, USA
10. Department of Public Health, University of West Florida, Pensacola, Florida, USA
11. Department of Athletic Training and Clinical Nutrition, University of Kentucky, Lexington, Kentucky, USA
12. Division of Endocrinology, Department of Internal Medicine, University of Kentucky, Lexington, Kentucky, USA
13. Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA
14. Oklahoma City VA Medical Center, Oklahoma City, Oklahoma, USA
15. Department of Physical Therapy, University of Kentucky, Lexington, Kentucky, USA
16. Division of Biomedical Informatics, Department of Internal Medicine, University of Kentucky, Lexington, Kentucky, USA
ais247@uky.edu
kpmaye2@uky.edu
ywen2@uky.edu
Show less
PDF
